The Incretin Space
A collection of collated data on incretin drug developments, including new drugs, new treatments and the future of incretins in medicine
Written by
The Incretin Space
Archive
GLP-1
+3
Jun 9, 2026
•
12 min read
ADA 2026: Retatrutide Revolution
A paradigm shift in diabetes and obesity arrives!
GLP-1
+6
May 29, 2026
•
10 min read
ADA Conference 2026 Preview
The Super Bowl Conference for diabetes and incretins!
GLP-1
+3
May 21, 2026
•
4 min read
Triumphant! Retatrutide matches bariatric surgery outcomes
Triumph 1 trial led to 19-30% weight loss depending on dose and time on trial.
GLP-1
+1
Apr 16, 2026
•
2 min read
ACHIEVEment Unlocked!
Orforglipron reduces the risk of cardiovascular events and all cause death in diabetic patients
GLP-1
+3
Mar 19, 2026
•
7 min read
Retatrutide TRANSCENDS diabetes in first phase 3 trial
A shift in what's possible for diabetes and obesity
